Kiwaki Takumi, Tanaka Hiroyuki, Akiyama Yutaka, Akaki Mayumi, Tomita Masaki, Kataoka Hiroaki
Section of Oncopathology and Regenerative Biology, Department of Pathology, Faculty of Medicine, University of Miyazaki, 5200, Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Clinical Laboratory, University of Miyazaki Hospital, Miyazaki, Japan.
J Med Case Rep. 2020 Jan 15;14(1):9. doi: 10.1186/s13256-019-2332-0.
True thymic hyperplasia is a rare condition characterized by enlargement of the thymus while its normal structure is retained. True thymic hyperplasia is known to accompany Graves' disease, but no association between true thymic hyperplasia and thyroid follicular tumor has been reported so far. We report a case of true thymic hyperplasia in a patient with a thyroid follicular tumor.
A 52-year-old Japanese man was referred to our hospital for evaluation of a thyroid mass and a mediastinal mass. His serum thyroglobulin level was high, and hemithyroidectomy was performed to remove the thyroid mass. The resected mass was diagnosed as a follicular tumor of uncertain malignant potential. After resection of the thyroid lesion, the patient's serum thyroglobulin levels were markedly decreased. Seven months later, the patient underwent resection of the mediastinal mass. On pathological examination, the mass was found to consist of lobules, which formed a corticomedullary structure with Hassall's bodies, indicating a normal thymic mass with hyperplastic thymic tissue, less organized cellular cords, and intermingled adipose tissue. Immunostaining for cytokeratin 19 and cytokeratin 7 indicated that the lesion was consistent with thymic tissue. The lesion was diagnosed as true thymic hyperplasia, and the histological findings suggested that secondary atrophy had occurred. No evidence of recurrence was observed at 24 months after surgery.
We present a case of a combination of true thymic hyperplasia and thyroidal follicular tumors that, to our knowledge, has not been reported previously. High serum thyroglobulin levels might play a role in hyperplasia of the thymus. Although true thymic hyperplasia is a rare disorder, it should be included in the differential diagnosis of a mediastinal mass in patients with thyroid disease.
真性胸腺增生是一种罕见病症,其特征为胸腺增大但仍保留正常结构。已知真性胸腺增生与格雷夫斯病相关,但迄今为止,尚未有关于真性胸腺增生与甲状腺滤泡肿瘤之间关联的报道。我们报告一例患有甲状腺滤泡肿瘤的真性胸腺增生患者。
一名52岁的日本男性因甲状腺肿物和纵隔肿物前来我院评估。其血清甲状腺球蛋白水平较高,遂行甲状腺半切除术以切除甲状腺肿物。切除的肿物被诊断为恶性潜能不确定的滤泡肿瘤。切除甲状腺病变后,患者的血清甲状腺球蛋白水平显著下降。七个月后,患者接受了纵隔肿物切除术。病理检查发现,该肿物由小叶组成,形成了带有哈氏小体的皮质髓质结构,表明是一个具有增生性胸腺组织、细胞索组织较少且伴有脂肪组织混杂的正常胸腺肿物。细胞角蛋白19和细胞角蛋白7的免疫染色表明该病变与胸腺组织一致。该病变被诊断为真性胸腺增生,组织学结果提示发生了继发性萎缩。术后24个月未观察到复发迹象。
我们报告了一例真性胸腺增生与甲状腺滤泡肿瘤合并的病例,据我们所知,此前尚未有过此类报道。高血清甲状腺球蛋白水平可能在胸腺增生中起作用。尽管真性胸腺增生是一种罕见疾病,但在甲状腺疾病患者纵隔肿物的鉴别诊断中应将其纳入考虑。